4D Molecular Therapeutics
FDMT
FDMT
88 hedge funds and large institutions have $221M invested in 4D Molecular Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 89 → 88 (-1)
Holders
88
Holding in Top 10
–
Calls
$760K
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$10.5M | |
| 3 | +$2.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.15M |
| 5 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
|
+$860K |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$3.88M | |
| 3 | -$3.31M | |
| 4 |
Renaissance Technologies
New York
|
-$1.53M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$1.07M |